Resistance Training with Blood Flow Restriction in Hemophilia

Launched by UNIVERSITY OF VALENCIA · Oct 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a special type of exercise program called resistance training combined with blood flow restriction for men with hemophilia. The goal is to see if this exercise can improve quality of life, reduce pain, and enhance physical and muscle function. Participants will take part in exercises like elbow and knee movements while wearing a band that restricts blood flow, which may help strengthen their muscles without putting them at risk for bleeding.

To be eligible for the study, participants need to be between 18 and 60 years old, diagnosed with hemophilia A or B, and currently receiving preventive treatment. They must be willing to exercise twice a week for eight weeks and have their doctor’s approval to participate. Throughout the program, participants can expect to engage in regular exercise sessions, and they will be evaluated before and after the program to measure any changes in their health and well-being. It's important to note that those who have had recent surgeries, major bleeding episodes, or are on certain medications may not be able to join.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of hemophilia A or B and undergoing prophylaxis;
• • willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations;
• • approval by their hematologist to participate in the exercise program;
• • age between 18 and 60 years;
• • informed consent signed.
• Exclusion Criteria:
• • the inability to attend exercise sessions at least twice a week for 8 consecutive weeks;
• • non adherence to instruction on proper exercise technique;
• • surgical procedures performed 6 weeks prior to or during the exercise program; - participation in any other form of exercise, not previously done, during the study;
• • changes in medication during the study;
• • a major bleeding episode that posed a risk or prevented exercise;
• • another hemostatic defect;
• • need for major surgery;
• • withdrawal of informed consent.